These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31107036)
1. Choosing wisely in cardiology: Five proposals from the Italian Association for Cardiovascular Prevention and Rehabilitation. Werren M; Copetti R; Gaibazzi N; Giada F; Faggiano A; Ricci C; Faggiano P Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31107036 [TBL] [Abstract][Full Text] [Related]
2. [Choosing wisely: the Top 5 list of the Italian Association of Hospital Cardiologists (ANMCO)]. Bobbio M; Abrignani MG; Caldarola P; Casolo G; Fattirolli F; Gabrielli D; Grimaldi M; Mazzotta G; Roncon L; Tozzi Q; Vallebona A G Ital Cardiol (Rome); 2014 Apr; 15(4):244-52. PubMed ID: 24873814 [TBL] [Abstract][Full Text] [Related]
3. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?]. Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042 [TBL] [Abstract][Full Text] [Related]
4. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding. Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ; J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105 [TBL] [Abstract][Full Text] [Related]
5. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564 [TBL] [Abstract][Full Text] [Related]
6. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. Wolk MJ; Bailey SR; Doherty JU; Douglas PS; Hendel RC; Kramer CM; Min JK; Patel MR; Rosenbaum L; Shaw LJ; Stainback RF; Allen JM; J Am Coll Cardiol; 2014 Feb; 63(4):380-406. PubMed ID: 24355759 [TBL] [Abstract][Full Text] [Related]
7. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)]. Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220 [No Abstract] [Full Text] [Related]
8. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations. Tantry US; Kereiakes DJ; Gurbel PA JACC Cardiovasc Interv; 2011 Apr; 4(4):365-80. PubMed ID: 21511216 [TBL] [Abstract][Full Text] [Related]
9. [Risk factors of upper gastrointestinal complications in outpatients on antiplatelet therapy: description and management]. Ducrocq G; Bigard MA; Marouene S; Delaage PH; Fabry C; Barthelemy P; Steg PG; Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):245-51. PubMed ID: 22579299 [TBL] [Abstract][Full Text] [Related]
10. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention. Jiang Z; Wu H; Duan Z; Wang Z; Hu K; Ye F; Zhang Z Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):636-41. PubMed ID: 23684576 [TBL] [Abstract][Full Text] [Related]
11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493 [TBL] [Abstract][Full Text] [Related]
12. The Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008). Part 3. National availability and organization of cardiac rehabilitation facilities. Official report of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (IACPR-GICR). Tramarin R; Ambrosetti M; De Feo S; Piepoli M; Riccio C; Griffo R; Monaldi Arch Chest Dis; 2008 Dec; 70(4):175-205. PubMed ID: 19263795 [TBL] [Abstract][Full Text] [Related]
13. Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology. Barillà F; Pelliccia F; Borzi M; Camici P; Cas LD; Di Biase M; Indolfi C; Mercuro G; Montemurro V; Padeletti L; Filardi PP; Vizza CD; Romeo F; J Cardiovasc Med (Hagerstown); 2017 Jan; 18(1):1-9. PubMed ID: 27635937 [TBL] [Abstract][Full Text] [Related]
14. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry. Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K; Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956 [TBL] [Abstract][Full Text] [Related]
15. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting. Yasuda H; Yamada M; Sawada S; Endo Y; Inoue K; Asano F; Takeyama Y; Yoshiba M Intern Med; 2009; 48(19):1725-30. PubMed ID: 19797827 [TBL] [Abstract][Full Text] [Related]
16. [ANMCO Position paper: Choosing Wisely - ANMCO proposals for 2023]. Lucà F; Gulizia MM; Abrignani MG; Benedetto FA; Bisceglia I; Bisignani G; Bobbio MC; Caldarola P; Canale ML; Caretta G; Ceravolo R; Chimenti C; Ciconte VA; Corda M; Cornara S; Di Fusco SA; Di Matteo I; Di Nora C; Favilli S; Francese GM; Gelsomino S; Gensini GF; Giubilato S; Grimaldi M; Nardi F; Navazio A; Parrini I; Pilleri A; Pozzi A; Rao CM; Riccio C; Rossini R; Vernero S; Gabrielli D; Oliva F; Colivicchi F G Ital Cardiol (Rome); 2023 Sep; 24(9):754-765. PubMed ID: 37642128 [TBL] [Abstract][Full Text] [Related]
17. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy. Casado Arroyo R; Polo-Tomas M; Roncalés MP; Scheiman J; Lanas A Heart; 2012 May; 98(9):718-23. PubMed ID: 22523056 [TBL] [Abstract][Full Text] [Related]
18. [ICAROS (Italian survey on CardiAc RehabilitatiOn and Secondary prevention after cardiac revascularization): temporary report of the first prospective, longitudinal registry of the cardiac rehabilitation network GICR/IACPR]. Griffo R; Temporelli PL; Fattirolli F; Ambrosetti M; Tramarin R; Vestri AR; De Feo S; Tavazzi L; Monaldi Arch Chest Dis; 2012 Jun; 78(2):73-8. PubMed ID: 23167148 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]. Bretagne JF Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029 [No Abstract] [Full Text] [Related]
20. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review. Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]